Issuu on Google+

17P Now, new studies offer hope for the prevention of premature births Your prescription. Your way.

We dge wood Pharmacy 4 0 5 He ron Drive , S uit e 20 0 S we de sboro, NJ 08 0 8 5 -17 4 9 call

Administered weekly, 17-alpha hydroxyprogesterone caproate (17P) has been reported to lower the rate of premature births by more than a third.* on a recent Maternal-Fetal Medicine Unit network study sponsored by the National Institute of Child Health and Human Development published in The New England Journal of Medicine on June 12, 2003.

fax

800.331.8272 8 0 0 .58 9 .42 5 0

e mail we b

p harm@we dge woodp harmacy.co m

we dge woodp harmacy.com

*Based

Š2004 Wedgewood Pharmacy

Each year half a million babies can’t wait to be born


17P Premature birth – a growing concern Some babies just can’t wait to be born. Nearly half a million babies are born every year before reaching 37 weeks of gestational age. And that number, representing 12% of all live births, continues to rise. Since 1981, prematurity has increased by 27% in the United States. All of the factors that are responsible for inducing preterm labor are currently unknown. Premature birth represents the biggest problem in obstetrics and is the leading cause of death within the first month of life.* For babies who survive, the list of problems that can go along with being born too soon is long. Premature infants can be plagued with lung problems, hearing loss, mental retardation, cerebral palsy, and more, with many effects lasting a lifetime.

New findings reported

Several recent studies report a new use for a commercially-unavailable drug, 17-alpha hydroxyprogesterone caproate. Study researchers announced that when 17P was administered through weekly injections to women deemed to be at high risk, premature deliveries were lowered by more than a third.* While the MFMU researchers report this treatment can be used to prevent early labor, they do not report it as an effective treatment for women whose labor has already begun. The results of these tests also suggest that treatment with 17P significantly reduced the likelihood of several complications in infants. 17-alpha hydroxyprogesterone caproate compound is available by prescription to obstetricians and their patients through Wedgewood Pharmacy.

To order call toll-free 800-331-8272 *For more information or a copy of the NEJM study article, call or visit us online at: w w w. w e d g e w o o d p h a r m a c y. c o m

Or you may also visit www.hydroxyprogesterone.com.

A word about Wedgewood

Wedgewood Pharmacy is a recognized leader in providing difficult-to-obtain medications. With over 20 years of experience, we’re experts at compounding new, discontinued, back-ordered or otherwise unavailable drugs so that we can meet your needs – and the unique needs of your patients. As one of the largest compounding pharmacies in the nation, we offer fast turnaround times, unmatched customer service, and quality you can count on. It’s no wonder more than 17,000 doctors rely on Wedgewood Pharmacy to deliver the compounded formulations they need to treat their patients. Our approach to meeting both physician and patient needs has evolved over the years into a very effective system. We closely monitor news of impending drug discontinuations, shortages, and progressive therapies so we can anticipate what you need – before you need it. Because of Wedgewood’s experience and commitment, your patients can continue to receive appropriate medication with no interruption. Furthermore, our strict quality control / quality assurance programs ensure every prescription meets your specifications. Wedgewood Pharmacy is committed to putting your needs – and those of your patients – first.


17P Brochure